ARCHIVES

NKTR-102 Shows 29 Percent Response in Phase II Study

This article is from The Cancer Letter archive.

Vol. 34 No. 9 | September 30, 2011

Download PDF Visit The Full Archive

Related Articles

NCI, Canary Foundation Fund Biomarker Studies In Lung Cancer Of Never-Smokers

May 8, 2009

In Brief: Tom Hall Names CMMI VP For Clinical Affairs; Rabson, Fauci Names to Institute Of Medicine

June 26, 1987

In Congress: Senate, House Reports List Priorities For NCI

August 8, 1997

Funding Opportunities: Lustgarten Foundation Request For Proposals; RFAs Available; NCI Grant Supplements.

June 20, 2003

Selumetinib Plus Docetaxel Effective in KRAS-Mutant Disease

January 25, 2013

NCI News Roundup: clinical Trials Initiatives Explained in Lectures Available Online

June 11, 1999